Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly
Abstract Background Maximizing the efficiency to screen amyloid-positive individuals in asymptomatic and non-demented aged population using blood-based biomarkers is essential for future success of clinical trials in the early stage of Alzheimer’s disease (AD). In this study, we elucidate the utilit...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2024-05-01
|
| Seri Bilgileri: | Alzheimer’s Research & Therapy |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s13195-024-01469-w |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|